Immunization of Healthcare Workers with Varicella Vaccine

Infection Control and Hospital Epidemiology

Volumn 19, Issue 5, 1998, Pages 348-353

  Lyznicki, James M ^a   Bezman, Rebecca J ^a   Genel, Myron ^a   Bresolin, Linda B ^a  

^a AMERICAN MEDICAL ASSOCIATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ADULT; ARTICLE; CHICKENPOX; CROSS INFECTION; HEALTH CARE PERSONNEL; HUMAN; MEDICAL SOCIETY; PRACTICE GUIDELINE; SAFETY; STANDARD; UNITED STATES; VACCINATION;

ADULT; AMERICAN MEDICAL ASSOCIATION; CHICKENPOX; CHICKENPOX VACCINE; CROSS INFECTION; GUIDELINES; HEALTH PERSONNEL; HUMANS; SAFETY; UNITED STATES; VACCINATION;

EID: 0032062173     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/647828     Document Type: Article

References (50)

1. Whitley RJ. Varicella-zoster virus. In: Mandell GR, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 4th ed. New York, NY: Churchill Livingstone; 1995:1345-1351.
2. Benenson AS. Control of Communicable Diseases Manual. 16th ed. Washington, DC: American Public Health Association; 1995.
3. Arvin AM. Varicella-zoster virus. Clin Microbiol Rev 1996;9:361-381.
4. Wharton M. The epidemiology of varicella-zoster infections. Infect Dis Clin North Am 1996;10:571-581.
5. Centers of Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices. MMWR 1996;45(RR-11):1-36.
6. Choo PW, Donahue JG, Manson JE. The epidemiology of varicella and its complications. J Infect Dis 1995;172:706-712.
7. Fairley CK, Miller E. Varicella-zoster epidemiology - a changing scene? J Infect Dis 1996;174(suppl 3):S314-S319.
8. Preblud SR. Varicella: complications and costs. Pediatrics 1986;78: 728-735.
9. Plotkin SA. Varicella vaccine. Pediatrics 1996;97:251-253.
10. Katz VL, Kuller JA, McMahon MJ, Warren MA, Wells SR. Varicella during pregnancy: maternal and fetal effects. West J Med 1995;163:446-450.
11. Seidman DS, Stevenson DK, Arvin AM. Varicella vaccine in pregnancy. BMJ 1996;313:701-702.
12. Pastuszak AL, Levy M, Schick B, Zuber C, Feldkamp M, Gladstone J, et al. Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med 1994;330:901-905.
13. Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994;343:1548-1551.
14. Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T, Isomura S. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974;2:1288-1290.
15. Merck Vaccine Division. Varivax. Manufacturer's Package Insert. West Point, PA: Merck & Co, Inc; 1995.
16. Committee on Infectious Diseases, American Academy of Pediatrics. Recommendations for the use of live attenuated varicella vaccine. Pediatrics 1995;95:791-796.
17. Weibel RE, Neff BJ, Kuter BJ, Guess HA, Rothenberger CA, Fitzgerald AJ, et al. Live attenuated varicella virus vaccine: efficacy trial in healthy children. N Engl J Med 1984;310:1409-1415.
18. White CJ, Kuter BJ, Hildebrand CS, Isgantis KL, Matthews H, Miller WJ, et al. Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989. Pediatrics 1991;87: 604-610.
19. Gershon AA, Steinberg SP, LaRussa P, Ferrara A, Hammerschlag M, Gelb L, NIAID Collaborative Varicella Vaccine Study Group. Immunization of healthy adults with live attenuated varicella vaccine. J Infect Dis 1988;158:132-137.
20. Kuter BJ, Ngai A, Patterson CM, Staehle BO, Cho I, Matthews H, et al. Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax) in healthy adolescents and adults. Vaccine 1995;13:967-972.
21. Gershon AA. Varicella-zoster virus: prospects for control. Adv Pediatr Infect Dis 1995;10:93-124.
22. Krause PR, Klinman DM. Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine. J Pediatr 1995;127:518-525.
23. Watson BM, Piercy SA, Plotkin SA, Starr SE. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. Pediatrics 1993;91:17-22.
24. Henderson DK. Nosocomial herpesvirus infections. In: Mandell GR, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 4th ed. New York, NY: Churchill Livingstone; 1995:2656-2666.
25. Weber DJ, Rutala WA, Hamilton H. Prevention and control of varicella-zoster infections in healthcare facilities. Infect Control Hosp Epidemiol 1996;17:694-705.
26. Meyers JD, MacQuarrie MB, Merigan TC, Jennison MH. Nosocomial varicella, part 1: outbreak in oncology patients at a children's hospital. West J Med 1979;130:196-199.
27. Leclair JM, Zaia JA, Levine MJ, Congdon RG, Goldmann DA. Airborne transmission of chickenpox in a hospital. N Engl J Med 1980;302:450-453.
28. Josephson A, Gombert ME. Airborne transmission of nosocomial varicella from localized zoster. J Infect Dis 1988;158:238-241.
29. Gustafson TL, Shehab Z, Brunell PA. Outbreak of varicella in a newborn intensive care nursery. Am J Dis Child 1984;138:548-550.
30. Ng PC, Lyon DJ, Wong MY, Fok TF, Wong W, Cheung KL, et al. Varicella exposure in a neonatal intensive care unit: emergency management and control measures. J Hosp Infect 1996;32:229-236.
31. Preblud SR. Nosocomial varicella: worth preventing, but how? Am J Public Health 1988;78:13-15.
32. Centers for Disease Control. Guideline for infection control in hospital personnel. MMWR 1983;4(suppl):1-24.
33. Haiduven DJ, Hench CR Stevens DA. Postexposure varicella management of nonimmune personnel: an alternative approach. Infect Control Hosp Epidemiol 1994;15:329-334.
34. Faoagali JL, Darcy DD. Chickenpox outbreak among the staff of a large, urban adult hospital: costs of monitoring and control. Am J Infect Control 1995;23:247-250.
35. Weber DJ, Rutala WA, Parham C. Impact and costs of varicella prevention in a university hospital. Am J Public Health 1988;78:19-23.
36. Haiduven-Griffiths D, Fecko H. Varicella in hospital personnel: a challenge for the infection control practitioner. Am J Infect Control 1987;15:207-211.
37. McKinney WP, Horowitz MM, Battlola RJ. Susceptibility of hospital-based health care personnel to varicella-zoster virus infections. Am J Infect Control 1989;17:26-30.
38. Gardner P, Eickhoff T, Poland GA, Gross P, Griffin M, LaForce M, et al. Adult immunization. Ann Intern Med 1996;12(1 pt 1):35-40.
39. US Preventive Services Task Force. Adult immunizations. In: Guide to Clinical Preventive Services. 2nd ed. Baltimore, MD: Williams & Wilkins; 1996:791-814.
40. American Academy of Pediatrics, American College of Obstetricians and Gynecologists. Guidelines for Perinatal Care. 4th ed. Washington, DC: American College of Obstetricians and Gynecologists; 1997.
41. Tsolia M, Gershon AA, Steinberh SP, Gelb L, NIAID Varicella Vaccine Collaborative Study Group. Live, attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of the varicella-zoster virus. J Pediatr 1990;116:184-189.
42. Diaz PS, Au D, Smith S, Amylon M, Link M, Smith S, et al. Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings. Pediatrics 1991;87:166-170.
43. Hughes P, LaRussa P, Pearce JM, Lepow M, Steinberg S, Gershon A. Transmission of varicella-zoster virus from a vaccinee with leukemia, demonstrated by polymerase chain reaction. J Pediatr 1994;124:932-935.
44. Watson B, Gupta R, Randall T, Starr S. Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine. J Infect Dis 1994;169:197-199.
45. Asano Y, Suga S, Yoshikawa T, Kobayashi I, Yazaki T, Shibata M, et al. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine. Pediatrics 1994;94:524-526.
46. Brunell PA, Taylor-Wiedeman J, Geiser CF, Frierson L, Lydick E. Risk of herpes zoster in children with leukemia: varicella vaccine compared with history of chickenpox. Pediatrics 1986;77:53-56.
47. Lawrence R, Gershon AA, Holzman R, Steinberg SP, NIAID Varicella Vaccine Collaborative Study Group. The risk of zoster after varicella vaccination in children with leukemia. N Engl J Med 1988;318:543-548.
48. Hardy I, Gershon AA, Steinberg SP, LaRussa P, NIAID Varicella Vaccine Collaborative Study Group. The incidence of zoster after immunization with live attenuated varicella vaccine: a study in children with leukemia. N Engl J Med 1991;325:1545-1550.
49. Tennenberg AM, Brassard JE, Van Lieu J, Drusin LM. Varicella vaccination for healthcare workers at a university hospital: an analysis of costs and benefits. Infect Control Hosp Epidemiol 1997;18:405-411.
50. Nettleman MD, Schmid M. Controlling varicella in the healthcare setting: the cost-effectiveness of using varicella vaccine in healthcare workers. Infect Control Hosp Epidemiol 1997;18:504-508.